Patients to pay no more than $35 a month Eli Lilly, Sanofi previously settled overcharging claims Novo Nordisk denies wrongdoing, pledges affordable insulin Jan 27 (Reuters) - Novo Nordisk (NOVOb ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.

Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products and could be used to respond to an emerging pandemic ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

The deceased and injured had come from Dera Ismail Khan to attend a wedding ceremony. He said that everyone in the house was sleeping in the morning and there was a power shutdown. They heard gun ...

Ten police personnel were martyred while six others were injured in a late-night terrorist attack on the Chodwan police station in Dera Ismail Khan. According to the Police, terrorists attacked the ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

THURSDAY, Jan. 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for ...

ISLAMABAD, Jan 23 (Reuters) - Pakistan's former Prime Minister Imran Khan, opens new tab called off reconciliatory talks with the government on Thursday, a week after a court handed him a 14-year ...

Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies.

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12,101.79 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...